| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.955 | 0.002 | 0.955 | Topoisomerase II inhibitor | 0.865 0.002 DBMET02166 0.924 0.002 DBMET02010 0.798 0.003 DBMET02165 | ||
| 0.903 | 0.001 | 0.903 | Antineoplastic antibiotic | 0.707 0.002 DBMET02166 0.737 0.002 DBMET02010 0.423 0.005 DBMET02165 | ||
| 0.749 | 0.006 | 0.784 | Antibacterial | 0.506 0.039 DBMET02166 0.784 0.004 DBMET02010 0.611 0.018 DBMET02165 | DBMET02010 | |
| 0.728 | 0.026 | 0.728 | Apoptosis agonist | 0.333 0.15 DBMET02166 0.646 0.04 DBMET02010 0.274 0.191 DBMET02165 | ||
| 0.683 | 0.005 | 0.683 | DNA damaging | 0.366 0.036 DBMET02166 0.645 0.006 DBMET02010 0.34 0.044 DBMET02165 | ||
| 0.658 | 0.004 | 0.658 | DNA intercalator | 0.264 0.015 DBMET02166 0.541 0.005 DBMET02010 0.212 0.023 DBMET02165 | ||
| 0.624 | 0.003 | 0.624 | Topoisomerase I inhibitor | 0.593 0.003 DBMET02166 0.36 0.007 DBMET02010 0.169 0.035 DBMET02165 | ||
| 0.617 | 0.003 | 0.617 | Topoisomerase II alpha inhibitor | 0.309 0.007 DBMET02166 0.568 0.004 DBMET02010 0.247 0.01 DBMET02165 | ||
| 0.582 | 0.004 | 0.582 | Alkylator | 0.226 0.02 DBMET02166 0.536 0.004 DBMET02010 0.264 0.015 DBMET02165 | ||
| 0.529 | 0.011 | 0.667 | DNA synthesis inhibitor | 0.445 0.017 DBMET02166 0.667 0.005 DBMET02010 0.521 0.012 DBMET02165 | DBMET02010 | |
| 0.535 | 0.039 | 0.535 | Transcription factor NF kappa B inhibitor | 0.229 0.143 DBMET02166 0.363 0.073 DBMET02010 0.199 0.17 DBMET02165 | ||
| 0.488 | 0.013 | 0.57 | Antimitotic | 0.57 0.008 DBMET02166 | DBMET02166 | |
| 0.499 | 0.033 | 0.504 | Immunosuppressant | 0.326 0.1 DBMET02166 0.504 0.032 DBMET02010 0.408 0.06 DBMET02165 | DBMET02010 | |
| 0.434 | 0.015 | 0.434 | RNA-directed DNA polymerase inhibitor | 0.359 0.023 DBMET02166 0.355 0.023 DBMET02010 0.284 0.035 DBMET02165 | ||
| 0.448 | 0.03 | 0.448 | Caspase 3 stimulant | 0.27 0.096 DBMET02010 | ||
| 0.342 | 0 | 0.342 | Antibiotic Anthracycline-like | 0.072 0.001 DBMET02166 0.089 0.001 DBMET02010 0.051 0.002 DBMET02165 | ||
| 0.318 | 0.019 | 0.336 | Peptidyltransferase inhibitor | 0.193 0.109 DBMET02166 0.336 0.015 DBMET02010 0.278 0.034 DBMET02165 | DBMET02010 | |
| 0.358 | 0.062 | 0.446 | Antithrombotic | 0.446 0.039 DBMET02010 0.241 0.133 DBMET02165 | DBMET02010 | |
| 0.313 | 0.044 | 0.313 | Angiogenesis stimulant | 0.216 0.086 DBMET02010 | ||
| 0.261 | 0.005 | 0.261 | DNA repair enzyme inhibitor | 0.151 0.031 DBMET02166 0.218 0.007 DBMET02010 0.131 0.053 DBMET02165 | ||
| 0.31 | 0.058 | 0.31 | Antioxidant | 0.194 0.118 DBMET02166 0.282 0.069 DBMET02010 0.178 0.134 DBMET02165 | ||
| 0.294 | 0.042 | 0.294 | Nitric oxide antagonist | 0.144 0.1 DBMET02166 0.216 0.062 DBMET02010 0.143 0.102 DBMET02165 | ||
| 0.319 | 0.073 | 0.319 | Apoptosis antagonist | 0.193 0.189 DBMET02010 | ||
| 0.24 | 0.007 | 0.268 | HIV-1 integrase (Strand Transfer) inhibitor | 0.268 0.005 DBMET02166 0.054 0.046 DBMET02010 | DBMET02166 | |
| 0.251 | 0.031 | 0.251 | Nitric-oxide synthase stimulant | 0.186 0.115 DBMET02166 0.182 0.123 DBMET02165 | ||
| 0.228 | 0.015 | 0.228 | Expectorant | 0.162 0.031 DBMET02010 0.103 0.066 DBMET02165 | ||
| 0.215 | 0.003 | 0.215 | Ca2+-transporting ATPase inhibitor | 0.201 0.003 DBMET02166 0.211 0.003 DBMET02010 0.19 0.004 DBMET02165 | ||
| 0.217 | 0.009 | 0.257 | HIV-1 integrase (3'-Processing) inhibitor | 0.257 0.006 DBMET02166 0.062 0.045 DBMET02010 0.057 0.051 DBMET02165 | DBMET02166 | |
| 0.285 | 0.083 | 0.285 | Immunostimulant | 0.269 0.089 DBMET02010 0.17 0.139 DBMET02165 | ||
| 0.241 | 0.046 | 0.252 | Hepatoprotectant | 0.252 0.043 DBMET02010 0.138 0.124 DBMET02165 | DBMET02010 | |
| 0.254 | 0.067 | 0.254 | Free radical scavenger | 0.189 0.107 DBMET02166 0.21 0.09 DBMET02010 0.158 0.136 DBMET02165 | ||
| 0.137 | 0.011 | 0.137 | ATPase (Vacuolar H+) inhibitor | 0.091 0.055 DBMET02010 | ||
| 0.133 | 0.008 | 0.133 | Protein 50S ribosomal subunit inhibitor | 0.107 0.011 DBMET02010 | ||
| 0.151 | 0.046 | 0.151 | Monophenol monooxygenase inhibitor | 0.113 0.066 DBMET02166 0.095 0.08 DBMET02165 | ||
| 0.123 | 0.022 | 0.191 | Selectin antagonist | 0.191 0.012 DBMET02010 | DBMET02010 | |
| 0.161 | 0.062 | 0.161 | NOS3 expression enhancer | 0.136 0.089 DBMET02010 | ||
| 0.16 | 0.066 | 0.16 | Interferon gamma antagonist | 0.154 0.072 DBMET02166 0.15 0.077 DBMET02165 | ||
| 0.117 | 0.027 | 0.117 | Transcription factor NF kappa B stimulant | 0.087 0.055 DBMET02010 | ||
| 0.301 | 0.215 | 0.343 | Antiinflammatory | 0.343 0.178 DBMET02010 | DBMET02010 | |
| 0.127 | 0.043 | 0.127 | AMP-activated protein kinase stimulant | |||
| 0.17 | 0.089 | 0.17 | P-glycoprotein inhibitor | |||
| 0.078 | 0.004 | 0.088 | Protein 30S ribosomal subunit inhibitor | 0.033 0.012 DBMET02166 0.088 0.004 DBMET02010 0.031 0.012 DBMET02165 | DBMET02010 | |
| 0.101 | 0.028 | 0.101 | Thioredoxin reductase inhibitor | 0.099 0.029 DBMET02166 0.092 0.038 DBMET02010 0.088 0.045 DBMET02165 | ||
| 0.075 | 0.005 | 0.077 | Antibiotic Aminoglycoside-like | 0.077 0.005 DBMET02010 | DBMET02010 | |
| 0.099 | 0.033 | 0.104 | Na+ K+ transporting ATPase inhibitor | 0.104 0.028 DBMET02010 0.072 0.058 DBMET02165 | DBMET02010 | |
| 0.149 | 0.083 | 0.173 | Melanin inhibitor | 0.153 0.077 DBMET02166 0.151 0.08 DBMET02010 0.173 0.057 DBMET02165 | DBMET02165 | |
| 0.2 | 0.138 | 0.2 | Transcription factor STAT inhibitor | 0.179 0.169 DBMET02166 | ||
| 0.155 | 0.098 | 0.24 | Lipocortins synthesis antagonist | 0.24 0.037 DBMET02166 0.176 0.074 DBMET02165 | DBMET02166 | |
| 0.183 | 0.13 | 0.183 | Hypoglycemic | |||
| 0.184 | 0.136 | 0.184 | 5 Hydroxytryptamine release stimulant | 0.181 0.139 DBMET02166 0.166 0.159 DBMET02165 | ||
| 0.075 | 0.028 | 0.228 | Bombesin 1 receptor agonist | 0.228 0.004 DBMET02166 0.071 0.031 DBMET02010 0.195 0.005 DBMET02165 | DBMET02166 | |
| 0.11 | 0.065 | 0.148 | Mucolytic | 0.148 0.033 DBMET02010 0.107 0.069 DBMET02165 | DBMET02010 | |
| 0.197 | 0.154 | 0.197 | Gastrin inhibitor | |||
| 0.147 | 0.107 | 0.147 | ATPase inhibitor | |||
| 0.056 | 0.034 | 0.056 | DNA helicase inhibitor | 0.056 0.035 DBMET02166 0.052 0.043 DBMET02165 | ||
| 0.041 | 0.02 | 0.041 | Glutamate (mGluR group II) agonist | 0.04 0.02 DBMET02166 0.031 0.029 DBMET02165 | ||
| 0.038 | 0.02 | 0.062 | Glutamate (mGluR8) antagonist | 0.062 0.005 DBMET02166 0.038 0.019 DBMET02010 0.06 0.005 DBMET02165 | DBMET02166 | |
| 0.115 | 0.098 | 0.254 | Protein kinase stimulant | 0.111 0.103 DBMET02166 0.254 0.025 DBMET02010 0.172 0.054 DBMET02165 | DBMET02010 | |
| 0.087 | 0.07 | 0.145 | Glutamate release inhibitor | 0.107 0.033 DBMET02166 0.145 0.011 DBMET02165 | DBMET02165 | |
| 0.036 | 0.02 | 0.036 | Glutamate (mGluR2) agonist | 0.034 0.021 DBMET02166 | ||
| 0.02 | 0.004 | 0.023 | Antibiotic Tetracycline-like | 0.023 0.003 DBMET02166 0.021 0.004 DBMET02010 0.02 0.004 DBMET02165 | DBMET02166 | |
| 0.048 | 0.037 | 0.058 | Topoisomerase II beta inhibitor | 0.054 0.027 DBMET02166 0.058 0.024 DBMET02165 | DBMET02165 | |
| 0.1 | 0.09 | 0.1 | Microtubule formation inhibitor | |||
| 0.015 | 0.009 | 0.015 | Antibiotic Macrolide-like | |||
| 0.066 | 0.063 | 0.066 | Glycine receptor agonist | |||
| 0.054 | 0.051 | 0.056 | Lipocortins synthesis agonist | 0.056 0.045 DBMET02166 0.056 0.045 DBMET02010 | DBMET02010 | |
| 0.026 | 0.024 | 0.026 | Factor VII inhibitor | |||
| 0.069 | 0.08 | 0.09 | Ornithine decarboxylase inhibitor | 0.09 0.056 DBMET02010 | DBMET02010 | |
| 0.059 | 0.07 | 0.11 | HIV-1 integrase inhibitor | 0.11 0.019 DBMET02166 | DBMET02166 | |
| 0.097 | 0.12 | 0.127 | Lipid peroxidase inhibitor | 0.127 0.087 DBMET02166 0.127 0.087 DBMET02165 | DBMET02165 | |
| 0.102 | 0.131 | 0.194 | Cell wall synthesis inhibitor | 0.194 0.033 DBMET02165 | DBMET02165 | |
| 0.049 | 0.087 | 0.068 | Neuraminidase (influenza) inhibitor | 0.068 0.038 DBMET02010 0.067 0.039 DBMET02165 | DBMET02010 | |
| 0.182 | 0.222 | 0.27 | Interleukin 2 agonist | 0.27 0.098 DBMET02010 0.254 0.114 DBMET02165 | DBMET02010 | |
| 0.101 | 0.144 | 0.166 | Mannose-6-phosphate isomerase inhibitor | 0.166 0.052 DBMET02166 | DBMET02166 | |
| 0.102 | 0.147 | 0.153 | Papain-like protease (SARS coronavirus) inhibitor | 0.153 0.031 DBMET02166 0.139 0.045 DBMET02165 | DBMET02166 | |
| 0.112 | 0.162 | 0.138 | Anesthetic general | 0.138 0.127 DBMET02166 | DBMET02166 | |
| 0.085 | 0.136 | 0.109 | Estrogen antagonist | 0.109 0.077 DBMET02166 | DBMET02166 | |
| 0.052 | 0.105 | 0.1 | CDC25A inhibitor | 0.1 0.027 DBMET02166 0.068 0.06 DBMET02010 0.097 0.029 DBMET02165 | DBMET02166 | |
| 0.037 | 0.091 | 0.105 | Cathepsin B inhibitor | 0.105 0.015 DBMET02166 | DBMET02166 | |
| 0.082 | 0.138 | 0.201 | Cyclooxygenase 3 inhibitor | 0.201 0.018 DBMET02010 0.126 0.071 DBMET02165 | DBMET02010 | |
| 0.032 | 0.095 | 0.065 | Neuraminidase inhibitor | 0.055 0.05 DBMET02010 0.065 0.038 DBMET02165 | DBMET02165 | |
| 0.021 | 0.092 | 0.036 | Glutamate (mGluR3) agonist | 0.036 0.015 DBMET02166 0.03 0.028 DBMET02165 | DBMET02166 | |
| 0.064 | 0.14 | 0.223 | Cystathionine beta-synthase inhibitor | 0.223 0.02 DBMET02166 0.178 0.03 DBMET02165 | DBMET02166 | |
| 0.014 | 0.095 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.017 DBMET02010 0.029 0.018 DBMET02165 | DBMET02165 | |
| 0.091 | 0.179 | 0.196 | Arachidonic acid antagonist | 0.196 0.037 DBMET02166 0.16 0.077 DBMET02165 | DBMET02166 | |
| 0.113 | 0.207 | 0.159 | Phospholipase C inhibitor | 0.159 0.09 DBMET02166 | DBMET02166 | |
| 0.07 | 0.169 | 0.269 | DOPA decarboxylase inhibitor | 0.269 0.003 DBMET02166 0.225 0.004 DBMET02165 | DBMET02166 | |
| 0.055 | 0.157 | 0.091 | UDP-glucose 4-epimerase inhibitor | 0.091 0.072 DBMET02166 | DBMET02166 | |
| 0.096 | 0.212 | 0.148 | Interleukin 6 antagonist | 0.148 0.092 DBMET02010 | DBMET02010 | |
| 0.091 | 0.212 | 0.152 | Adenylate cyclase stimulant | 0.126 0.111 DBMET02166 0.152 0.059 DBMET02165 | DBMET02165 | |
| 0.071 | 0.194 | 0.138 | Interleukin 4 antagonist | 0.138 0.062 DBMET02165 | DBMET02165 | |
| 0.043 | 0.171 | 0.1 | Glutamate (mGluR6) antagonist | 0.092 0.014 DBMET02166 0.1 0.011 DBMET02165 | DBMET02165 | |
| 0.041 | 0.173 | 0.065 | Heme oxygenase stimulant | 0.065 0.034 DBMET02166 0.057 0.055 DBMET02165 | DBMET02166 | |
| 0.02 | 0.156 | 0.043 | Neurokinin 2 agonist | 0.043 0.027 DBMET02166 0.039 0.032 DBMET02165 | DBMET02166 | |
| 0.075 | 0.217 | 0.108 | Transcription factor STAT6 inhibitor | 0.108 0.084 DBMET02166 | DBMET02166 | |
| 0.052 | 0.197 | 0.101 | Estrogen receptor beta antagonist | 0.101 0.063 DBMET02166 0.088 0.087 DBMET02165 | DBMET02166 | |
| 0.063 | 0.209 | 0.142 | Photosensitizer | 0.128 0.048 DBMET02166 0.142 0.036 DBMET02165 | DBMET02165 | |
| 0.069 | 0.215 | 0.162 | Protein-tyrosine phosphatase inhibitor | 0.162 0.068 DBMET02166 0.136 0.094 DBMET02165 | DBMET02166 | |
| 0.005 | 0.152 | 0.02 | Cathepsin S inhibitor | 0.02 0.013 DBMET02166 | DBMET02166 | |
| 0.035 | 0.194 | 0.081 | Telomerase inhibitor | 0.081 0.044 DBMET02166 | DBMET02166 | |
| 0.184 | 0.346 | 0.4 | Caspase 9 stimulant | 0.352 0.144 DBMET02166 0.362 0.136 DBMET02010 0.4 0.111 DBMET02165 | DBMET02165 | |
| 0.034 | 0.201 | 0.066 | Adenine nucleotide translocase inhibitor | 0.066 0.019 DBMET02010 | DBMET02010 | |
| 0.051 | 0.22 | 0.092 | Interleukin 5 antagonist | 0.092 0.051 DBMET02165 | DBMET02165 | |
| 0.169 | 0.339 | 0.266 | MAP kinase kinase 6 inhibitor | 0.266 0.17 DBMET02166 | DBMET02166 | |
| 0.052 | 0.233 | 0.104 | Alpha-N-acetylglucosaminidase inhibitor | 0.104 0.097 DBMET02165 | DBMET02165 | |
| 0.024 | 0.215 | 0.07 | CDC25B inhibitor | 0.07 0.037 DBMET02166 0.064 0.046 DBMET02165 | DBMET02166 | |
| 0.068 | 0.282 | 0.3 | Interleukin agonist | 0.227 0.097 DBMET02166 0.226 0.097 DBMET02010 0.3 0.048 DBMET02165 | DBMET02165 | |
| 0.042 | 0.272 | 0.099 | Amylase inhibitor | 0.099 0.097 DBMET02165 | DBMET02165 | |
| 0.022 | 0.26 | 0.138 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.138 0.023 DBMET02166 0.091 0.043 DBMET02165 | DBMET02166 | |
| 0.036 | 0.276 | 0.12 | Anabolic | 0.095 0.07 DBMET02166 0.12 0.04 DBMET02165 | DBMET02165 | |
| 0.061 | 0.305 | 0.129 | Hexokinase inhibitor | 0.129 0.105 DBMET02166 | DBMET02166 | |
| 0.122 | 0.369 | 0.341 | Calcium channel activator | 0.251 0.146 DBMET02166 0.341 0.056 DBMET02165 | DBMET02165 | |
| 0.077 | 0.324 | 0.19 | Neurotrophic factor enhancer | 0.19 0.087 DBMET02166 0.152 0.136 DBMET02165 | DBMET02166 | |
| 0.031 | 0.288 | 0.156 | Creatine kinase inhibitor | 0.156 0.021 DBMET02166 0.142 0.027 DBMET02165 | DBMET02166 | |
| 0.025 | 0.285 | 0.13 | 5-Lipoxygenase inhibitor | 0.13 0.046 DBMET02166 0.09 0.071 DBMET02165 | DBMET02166 | |
| 0.024 | 0.291 | 0.06 | Purinergic P2X1 antagonist | 0.06 0.043 DBMET02166 | DBMET02166 | |
| 0.012 | 0.281 | 0.054 | Alcohol oxidase inhibitor | 0.053 0.042 DBMET02166 0.054 0.04 DBMET02165 | DBMET02165 | |
| 0.035 | 0.313 | 0.078 | Estrogen receptor alpha antagonist | 0.078 0.052 DBMET02166 0.07 0.067 DBMET02165 | DBMET02166 | |
| 0.022 | 0.317 | 0.092 | GABA aminotransferase inhibitor | 0.092 0.034 DBMET02166 0.069 0.063 DBMET02165 | DBMET02166 | |
| 0.04 | 0.338 | 0.124 | Toll-Like receptor 4 antagonist | 0.124 0.04 DBMET02010 | DBMET02010 | |
| 0.043 | 0.343 | 0.175 | Aldehyde dehydrogenase inhibitor | 0.175 0.035 DBMET02166 0.112 0.08 DBMET02165 | DBMET02166 | |
| 0.029 | 0.332 | 0.085 | Keratolytic | 0.07 0.064 DBMET02166 0.085 0.042 DBMET02165 | DBMET02165 | |
| 0.012 | 0.316 | 0.043 | GHS receptor antagonist | 0.043 0.01 DBMET02166 0.034 0.019 DBMET02165 | DBMET02166 | |
| 0.007 | 0.314 | 0.062 | Dopamine D5 agonist | 0.062 0.011 DBMET02166 0.043 0.024 DBMET02165 | DBMET02166 | |
| 0.026 | 0.333 | 0.066 | Glutamate dehydrogenase inhibitor | 0.066 0.063 DBMET02165 | DBMET02165 | |
| 0.014 | 0.323 | 0.035 | Glutamate (mGluR8) agonist | 0.035 0.033 DBMET02166 | DBMET02166 | |
| 0.046 | 0.36 | 0.167 | Interleukin antagonist | 0.167 0.106 DBMET02165 | DBMET02165 | |
| 0.007 | 0.323 | 0.028 | Cathepsin K inhibitor | 0.028 0.017 DBMET02166 | DBMET02166 | |
| 0.037 | 0.362 | 0.106 | Granulocyte macrophage colony stimulating factor agonist | 0.106 0.027 DBMET02166 | DBMET02166 | |
| 0.103 | 0.437 | 0.292 | Tyrosine 3 hydroxylase inhibitor | 0.292 0.037 DBMET02166 0.235 0.084 DBMET02165 | DBMET02166 | |
| 0.089 | 0.426 | 0.232 | Sodium/bile acid cotransporter inhibitor | 0.232 0.148 DBMET02165 | DBMET02165 | |
| 0.055 | 0.398 | 0.135 | Sigma receptor agonist | 0.135 0.098 DBMET02166 | DBMET02166 | |
| 0.014 | 0.37 | 0.053 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.053 0.038 DBMET02166 | DBMET02166 | |
| 0.121 | 0.486 | 0.192 | MAP kinase kinase 3 inhibitor | 0.192 0.148 DBMET02166 0.187 0.165 DBMET02165 | DBMET02166 | |
| 0.013 | 0.38 | 0.095 | Glutamate decarboxylase inhibitor | 0.081 0.043 DBMET02166 0.095 0.033 DBMET02165 | DBMET02165 | |
| 0.07 | 0.437 | 0.199 | Cholesterol antagonist | 0.199 0.165 DBMET02165 | DBMET02165 | |
| 0.038 | 0.408 | 0.15 | Heat shock protein 90 alpha antagonist | 0.15 0.086 DBMET02166 | DBMET02166 | |
| 0.012 | 0.384 | 0.096 | Phenylalanine 4-hydroxylase inhibitor | 0.096 0.028 DBMET02165 | DBMET02165 | |
| 0.005 | 0.383 | 0.05 | Factor IX inhibitor | 0.017 0.014 DBMET02010 0.05 0.004 DBMET02165 | DBMET02165 | |
| 0.031 | 0.408 | 0.083 | MAP kinase kinase 7 inhibitor | 0.083 0.037 DBMET02166 0.073 0.069 DBMET02165 | DBMET02166 | |
| 0.067 | 0.471 | 0.196 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.163 0.121 DBMET02166 0.196 0.076 DBMET02165 | DBMET02165 | |
| 0.04 | 0.444 | 0.099 | Adenylate kinase inhibitor | 0.099 0.068 DBMET02165 | DBMET02165 | |
| 0.007 | 0.428 | 0.057 | Growth hormone secretagogue receptor antagonist | 0.057 0.015 DBMET02166 0.039 0.023 DBMET02165 | DBMET02166 | |
| 0.099 | 0.54 | 0.266 | 5 Hydroxytryptamine uptake stimulant | 0.266 0.067 DBMET02166 0.215 0.125 DBMET02165 | DBMET02166 | |
| 0.11 | 0.56 | 0.526 | Calcium channel L-type activator | 0.313 0.146 DBMET02166 0.339 0.126 DBMET02010 0.526 0.019 DBMET02165 | DBMET02165 | |
| 0.023 | 0.474 | 0.104 | HIV-1 integrase (Overall Integration) inhibitor | 0.104 0.051 DBMET02166 0.102 0.053 DBMET02165 | DBMET02166 | |
| 0.093 | 0.545 | 0.3 | 5 Hydroxytryptamine release inhibitor | 0.3 0.165 DBMET02166 0.272 0.199 DBMET02165 | DBMET02166 | |
| 0.034 | 0.51 | 0.16 | Succinate dehydrogenase inhibitor | 0.16 0.095 DBMET02166 0.138 0.137 DBMET02165 | DBMET02166 | |
| 0.04 | 0.519 | 0.171 | Cyclic AMP phosphodiesterase inhibitor | 0.171 0.121 DBMET02165 | DBMET02165 | |
| 0.011 | 0.502 | 0.082 | Beta adrenoreceptor antagonist | 0.082 0.026 DBMET02165 | DBMET02165 | |
| 0.031 | 0.524 | 0.079 | D-Ala-D-Ala ligase inhibitor | 0.079 0.072 DBMET02166 | DBMET02166 | |
| 0.012 | 0.508 | 0.137 | Glutamate receptor antagonist | 0.125 0.069 DBMET02166 0.137 0.06 DBMET02165 | DBMET02165 | |
| 0.052 | 0.549 | 0.251 | Histamine release inhibitor | 0.251 0.155 DBMET02166 0.216 0.184 DBMET02165 | DBMET02166 | |
| 0.029 | 0.526 | 0.106 | NADPH oxidase inhibitor | 0.106 0.103 DBMET02166 | DBMET02166 | |
| 0.025 | 0.523 | 0.115 | Adenylate cyclase inhibitor | 0.115 0.072 DBMET02165 | DBMET02165 | |
| 0.029 | 0.532 | 0.292 | Aldehyde oxidase inhibitor | 0.292 0.068 DBMET02166 0.287 0.07 DBMET02165 | DBMET02166 | |
| 0.019 | 0.524 | 0.091 | GABA C receptor rho-1 antagonist | 0.091 0.076 DBMET02166 | DBMET02166 | |
| 0.025 | 0.534 | 0.119 | Electron transport complex I inhibitor | 0.119 0.049 DBMET02165 | DBMET02165 | |
| 0.033 | 0.552 | 0.129 | GABA C receptor rho-2 antagonist | 0.129 0.108 DBMET02166 | DBMET02166 | |
| 0.014 | 0.541 | 0.098 | GABA C receptor antagonist | 0.098 0.081 DBMET02166 | DBMET02166 | |
| 0.056 | 0.613 | 0.361 | GABA C receptor rho-3 antagonist | 0.361 0.08 DBMET02166 0.25 0.154 DBMET02165 | DBMET02166 | |
| 0.014 | 0.574 | 0.105 | GABA C receptor agonist | 0.105 0.062 DBMET02166 0.09 0.079 DBMET02165 | DBMET02166 | |
| 0.026 | 0.591 | 0.311 | Peroxidase inhibitor | 0.159 0.073 DBMET02166 0.311 0.035 DBMET02165 | DBMET02165 | |
| 0.016 | 0.599 | 0.099 | Somatostatin 1 agonist | 0.099 0.035 DBMET02165 | DBMET02165 | |
| 0.01 | 0.595 | 0.042 | Glutamate (mGluR group III) antagonist | 0.042 0.034 DBMET02166 | DBMET02166 | |
| 0.019 | 0.611 | 0.187 | Lipoxygenase inhibitor | 0.187 0.155 DBMET02166 | DBMET02166 | |
| 0.009 | 0.616 | 0.065 | Pregnane X receptor antagonist | 0.054 0.049 DBMET02166 0.065 0.021 DBMET02165 | DBMET02165 | |
| 0.006 | 0.614 | 0.136 | MAO A inhibitor | 0.136 0.046 DBMET02166 | DBMET02166 | |
| 0.016 | 0.633 | 0.128 | Dual specificity phosphatase inhibitor | 0.128 0.124 DBMET02166 | DBMET02166 | |
| 0.007 | 0.641 | 0.069 | NMDA receptor agonist | 0.069 0.037 DBMET02166 0.059 0.049 DBMET02165 | DBMET02166 | |
| 0.032 | 0.671 | 0.171 | Superoxide dismutase inhibitor | 0.171 0.155 DBMET02166 | DBMET02166 | |
| 0.003 | 0.645 | 0.054 | NMDA receptor glycine site agonist | 0.054 0.052 DBMET02166 | DBMET02166 | |
| 0.008 | 0.663 | 0.125 | Mcl-1 antagonist | 0.125 0.119 DBMET02166 | DBMET02166 | |
| 0.002 | 0.662 | 0.033 | NMDA receptor subunit 3A antagonist | 0.033 0.032 DBMET02165 | DBMET02165 | |
| 0.004 | 0.666 | 0.141 | MAO inhibitor | 0.141 0.064 DBMET02166 | DBMET02166 | |
| 0.005 | 0.68 | 0.063 | Beta 2 adrenoreceptor agonist | 0.063 0.039 DBMET02165 | DBMET02165 | |
| 0.009 | 0.688 | 0.076 | Cathepsin G inhibitor | 0.076 0.047 DBMET02165 | DBMET02165 | |
| 0.005 | 0.694 | 0.059 | Beta 2 adrenoreceptor antagonist | 0.059 0.025 DBMET02165 | DBMET02165 | |
| 0.004 | 0.701 | 0.05 | Beta 1 adrenoreceptor antagonist | 0.05 0.046 DBMET02165 | DBMET02165 | |
| 0.009 | 0.729 | 0.196 | 12-Lipoxygenase inhibitor | 0.196 0.156 DBMET02166 | DBMET02166 | |
| 0.007 | 0.747 | 0.161 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.161 0.129 DBMET02166 | DBMET02166 | |
| 0.007 | 0.761 | 0.063 | Beta 3 adrenoreceptor antagonist | 0.063 0.048 DBMET02165 | DBMET02165 | |
| 0.006 | 0.793 | 0.094 | Ferrochelatase inhibitor | 0.094 0.078 DBMET02165 | DBMET02165 | |
| 0.003 | 0.793 | 0.093 | NMDA receptor antagonist | 0.08 0.066 DBMET02166 0.093 0.052 DBMET02165 | DBMET02165 | |
| 0.008 | 0.844 | 0.137 | Neurotensin receptor agonist | 0.137 0.136 DBMET02166 | DBMET02166 | |
| 0.005 | 0.845 | 0.099 | Bronchodilator | 0.099 0.066 DBMET02165 | DBMET02165 | |
| 0.003 | 0.888 | 0.089 | Adrenaline agonist | 0.089 0.046 DBMET02165 | DBMET02165 | |
| 0.009 | 0.926 | 0.104 | Nav1.4 sodium channel blocker | 0.104 0.07 DBMET02165 | DBMET02165 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |